The Monitor Daily

Thursday, January 28, 2021
Log in

As a participant in the Amazon Services LLC Associates Program, this site may earn from qualifying purchases. We may also earn commissions on purchases from other retail websites.

  • Home
  • Politics & National News
  • Business News
  • Tech & Science
  • Health & Lifestyle
  • About us
    • Contact US
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Stormy Planet
    • US Surgeon Performs Face Transplant
    • 2017 MTV VMAs Nominations Are In And Voting Is Now Open
    • Bright House: Free McAfee AntiVirus and Adult Controls
    • Antarctic Yeti Crab Gets Formal Scientific Name
    • Spiders Take Over Australian Town
    • Interesting Facts About the Apollo 11 Mission
    • Social Smoking or The New Landmark of Elegance Among Young Women
    • Rare Weasel Returns To Washington State

Pages

  • About The Monitor Daily
  • Contact US
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use

Recent Posts

  • Precisely what is Administration Buyback? Feb 12, 2020
  • Precisely what is Administration Buyback? Feb 12, 2020
  • Where by do Registered requests get kept Dec 1, 2019
  • Find a Star of the event on the Submit Purchase New bride List May 19, 2019
  • Locate Really enjoy On the internet Apr 30, 2019
  • Get Love On the net Apr 12, 2019
  • NYC Man Snaps Photo of the Victim After Sucker-Punching Him in Broad Daylight Jun 29, 2018

Kite Pharma Patient’s Death Is Unrelated To The Treatment

By Leave a Comment

Kite Pharma says patient's death is not related to the treatment

Kite Pharma Incorporated

Kite Pharma patient’s death is not related to the experimental cancer treatment that the patient was receiving, according to the company.

Arie S. Belldegrun, Kite’s Chief Executive, addressed the problem during a conference call. They admitted that the cancer patient died while receiving KTE-C19 cell therapy for non-Hodgkin’s lymphoma. Still, they firmly state that there is no connection between the patient’s death and the cancer treatment.

The company has conducted an in-depth investigation of the case. The clinical investigator found no link between the death of the patient and the product being used to treat the disease.

The Food and Drug Administration agreed that the company should continue the trial and still enroll new patients.

KTE-C19 represents experimental therapy and it is used on patients who have aggressive non-Hodgkin’s lymphoma if prior chemotherapy treatments have failed and the patients have very little chance of recovering. This kind of therapy involves a genetic modification of the patients’ T white blood cells so those cells can attack the cancerous cells.

Belldegrun said this type of therapy has shown great results even in the most desperate patients who were very sick due to some of the worst types of aggressive cancers. In those cases the tumors would easily melt away in a matter of weeks.

The company strongly believes in the product they are working on and it seems that in some patients the cancer has disappeared completely. The next step they will take would be to test how effective this drug will be in time.

Belledegrun asked the investors to relax as the company remains on track, even after the death of a patient. He stated that the company is excited about their clinical responses and said the drug could be manufactured and delivered to some clinical sites.

He also mentioned that Kite Pharma will file an application to the Food and Drug Administration for a biologics license by the end of next year. This means the KTE-C19 treatment that Kite has been working on might be available to the public as soon as 2017.

Wall Street analysts believe the company won’t generate positive earnings until 2018. Moreover, investors should be aware of specific risks, such as Kite’s treatment safety issues, because the safety of the KTE-C19 treatment remains unproven.

Kite Pharma Incorporated will shed more light on this subject in December, at the American Society of Hematology annual meeting, taking place in Orlando, Florida.

Photo credits: Content.nasdaq.com

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Health & Lifestyle

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 34 other subscribers

Operation Paperclip

Remembering Georg von Tiesenhausen, Last Member of Von Braun’s Rocket Team

By Leave a Comment

giant ground sloths on white background

It Seems that Giant Sloths Once Roamed Earth, and Humans Used to Hunt Them? (Study)

By Leave a Comment

sn 2001ig supernova explosion and images of its stars

A Star Escaped a Supernova Explosion, and NASA Snapped its Picture

By Leave a Comment

ngc 6420 galaxy resembling a giant butterfly

Hubble Spots Giant Butterfly Formed by a Black Hole and Stellar Winds (Study)

By Leave a Comment

infrared image of a dog

Space Technology Could Help Protect Earth’s Endangered Species

By Leave a Comment

snake slithering on a beige background

Kirigami Skin Is Helping a Soft Robot Slither Like a Snake (Study)

By Leave a Comment

woolly mammoth

Ice Age Tracks Reveal How Young Mammoths Cared for Adult Ones (Study)

By Leave a Comment

High Priestess tomb.

Archaeologists Discovered 4400-Years-Old High Priestess Tomb Near Cairo

By Leave a Comment

dwarf galaxies

Dwarf Galaxies Challenge the Entire Dark Matter Cosmology (Study)

By Leave a Comment

NASA Scientists and Food Experiments

NASA Scientists to Test if Astronauts Could Eat Their Own Poo

By Leave a Comment

KFC Smoky Wings Box Can Turn into Awesome Drone

By Leave a Comment

Tesla Model S

Tesla Model S Involved in Autopilot Malfunction Accident

By Leave a Comment

Duke Nukem.

John Cena Cold Feature in Duke Nukem Movie

By Leave a Comment

Battlefield One

Battlefield One Apocalypse DLC to Land in February

By Leave a Comment

Related Articles

  • eye procedure

    Queensland Mother Mutilated After Non-Invasive Eye Procedure Goes Sideways

  • HIV

    Northwest Arkansas Man Sentenced to 50 Years in Prison for Contracting HIV with the Purpose of Infecting Others

  • Meditation

    Yale Scientists Pinpointed the Brain Area for Spiritual Experiences

  • artificial intelligence

    Artificial Intelligence Outperforms Dermatologist in Melanoma Diagnosis

  • pill

    Arlington Doctor Gets 3 Years in Prison for Slipping Abortion Pill in Woman’s Tea

  • back of woman with short gray hair

    New Study Proposes Another Possible Cause for Gray Hair (Study)

  • two people jogging

    Being Physically Active Can Reportedly Make You Happier (Study)

  • OCD Twins Commit Suicide

    OCD Twins Committed Suicide, Freemont County Sheriff Confirms

  • fingerprint

    You Might Have Traces of Class A Drugs on Your Fingerprints

  • Bariatric surgery

    Star of ‘My 600-Lbs Life’ Dies of Heart Attack Following Bariatric Surgery

Categories

  • Business News
  • Entertainment
  • Featured
  • Health & Lifestyle
  • Nature
  • Politics & National
  • Sports
  • Tech & Science
  • US
  • World

Copyright © 2021 TheMonitorDaily.com

About · Privacy Policy · Terms of Use · Sitemap · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.